NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
41 hedge funds and large institutions have $109M invested in NKGen Biotech, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.8M | |
| 2 | +$5.08M | |
| 3 | +$2.47M | |
| 4 |
CFIA
Cantor Fitzgerald Investment Advisors
New York
|
+$2.46M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$1.69M |
Top Sellers
| 1 | -$2.66M | |
| 2 | -$1.94M | |
| 3 | -$1.7M | |
| 4 |
EIP
Easterly Investment Partners
Beverly,
Massachusetts
|
-$485K |
| 5 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
-$484K |